Bryn Martin
Vice President of Research, Drug Delivery, and CSF Sciences at Alcyone Lifesciences - Lowell, MA, US
Bryn Martin's Colleagues at Alcyone Lifesciences
Bryn Martin's Contact Details
978-709-1946
Moscow,Idaho,United States
Alcyone Lifesciences
Bryn Martin's Company Details
Alcyone Therapeutics is a biotechnology company developing precision therapies for neurological disorders with high unmet medical needs. The company integrates innovation in neuroscience, precision dosing platforms and in-house manufacturing capabilities to deliver transformative therapies to patients. Alcyone leverages the synergy between FalconTM, the company's proprietary intrathecal precising dosing platform that incorporates deep knowledge of CSF fluid dynamics, computational modeling and bioengineering, and multiple novel genetic therapy platforms developed at the Abigail Wexner Research Institute at Nationwide Children's Hospital (AWRI). This comprehensive approach allows for the optimization of central nervous system (CNS) dosing and delivery to better target the pathophysiology and anatomy specific to various neurological disease areas. Alcyone's lead programs target the treatment of Rett syndrome and IGHMBP2-Related Diseases (IRD).